Development and responsiveness of the coronary heart disease scale in the patient reported outcomes instruments system for chronic diseases
10.3760/cma.j.issn.1674-2907.2018.17.002
- VernacularTitle:慢性病患者报告结局测定量表体系之冠心病量表的研制及反应度评价
- Author:
Chuanmeng ZHANG
1
,
2
;
Zhiwen HUANG
;
Chonghua WAN
;
Zheng YANG
;
Chuanzhi XU
Author Information
1. 225300 江苏省泰州市人民医院中心实验室
2. 523808 东莞,广东医科大学人文与管理学院生命质量与应用心理研究中心
- Keywords:
Chronic disease;
Coronary heart disease;
Patient reported outcomes;
Scale;
Responsiveness
- From:
Chinese Journal of Modern Nursing
2018;24(17):1991-1995
- CountryChina
- Language:Chinese
-
Abstract:
Objective To develop the coronary heart disease (CHD) scale in the patient reported outcomes instruments system for chronic diseases (PROISCD-CHD), to assess its responsiveness and to offer a basis for clinical application.Methods The scale was developed by combining general and specific modules in accordance with the process by China Food and Drug Administration (CFDA). PROISCD-CHD was used to score the patient reported outcomes in 157 CHD patients before and after treatment in order to assess its responsiveness. The pairedt test and the responsiveness indicator before and after adopting the scale for treatment were used to analyze the data.Results The developed PROISCD-CHD included 30 items in the general module and 15 items in the specific module. According to the pairedt test, there was statistically significant difference in all aspects/dimensions other than ability and activity limited, positive emotions (P<0.05). In terms of the responsiveness indicator, the value range forSRM/ES andCR was 0.20-0.50 and 5.00％-15.00％, respectively, indicating the responsiveness was medium, except for some aspects/dimensions. Conclusions The general and specific modules in PROISCD-CHD includes the full content of CHD. Meanwhile, it has a certain responsiveness, and can be an assessment tool for China's patient reported outcomes for CHD.
